从慢性炎症到免疫逃生:绘制瘤微环境在细胞癌中的演变
Hanjun Xu1, Baojun Tu2, Hui Li3
1Department of Urology, Taizhou Second People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Frontiers in immunology
|November 20, 2025
概括
细胞癌 (RCC) 是由慢性炎症和免疫细胞排除形成的. 结合免疫检查点封锁与向血管或肌部件的策略,可以改善癌的免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 细胞癌 (RCC) 在慢性炎症微环境中发展.
- 瘤免疫微环境 (TIME) 动态涉及血管生成,新陈代谢和免疫信号.
- 缺氧和炎症维持了像NF-κB/STAT3和HIF-VEGF这样的信号通路.
研究的目的:
- 了解瘤微环境中的因素的复杂相互作用.
- 将特定的生物回路与癌症阶段和治疗反应联系起来.
- 为RCC开发改进的生物标志物和治疗策略.
主要方法:
- 分析单细胞和空间数据以映射时间异质性.
- 研究信号通路,包括NF-κB/STAT3,HIF-VEGF和IFN-γ.
- 整合性生物标志物的开发和验证.
主要成果:
- 确定了一种"化学激素检查点悖论"和除了CD8+T细胞之外的树皮壁垒.
- 在透明细胞RCC.中描述了免疫炎症,免疫排除和免疫沙漠表型.
- 证明了结合IFN-γ,血管新生, stromal 和空间数据的整合生物标志物优于单个测试.
结论:
- 提出了一个模块化视角,将生物电路与治疗联系起来.
- 建议采用联合策略,包括血管正常化或肌层重编程以及免疫检查点阻塞.
- 纵向免疫监测可以指导癌的精确免疫治疗.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K


